Tiny sensor tracks blood sugar in preterm babies to boost brain health
NCT ID NCT05436925
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study placed a continuous glucose monitor (CGM) on 24 preterm infants born before 31 weeks to track their blood sugar levels for up to 10 days. The goal was to see how well the device detects high and low blood sugar, and to link those readings to the babies' growth and brain development over time. The CGM was used for research only, not to guide treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexcom G6 continuous glucose monitor (CGM)
What this could lead to
If successful, this could help doctors better manage blood sugar in preterm infants, potentially improving their growth and brain development.
What could go wrong
This is a small, early-stage study with only 24 infants, so results may not apply to all preterm babies. The CGM is used for research only, not for diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERGLYCEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States